Candriam Luxembourg S.C.A. lessened its position in AMBEV S A/S (NYSE:ABEV) by 96.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,200 shares of the company’s stock after selling 414,170 shares during the period. Candriam Luxembourg S.C.A.’s holdings in AMBEV S A/S were worth $40,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. JustInvest LLC acquired a new stake in shares of AMBEV S A/S in the 1st quarter worth about $26,000. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of AMBEV S A/S in the 1st quarter worth about $27,000. Wolverine Trading LLC acquired a new stake in shares of AMBEV S A/S in the 1st quarter worth about $28,000. Raymond James Financial Services Advisors Inc. acquired a new stake in shares of AMBEV S A/S in the 2nd quarter worth about $31,000. Finally, Sontag Advisory LLC acquired a new stake in shares of AMBEV S A/S in the 1st quarter worth about $32,000. 8.58% of the stock is currently owned by institutional investors and hedge funds.
AMBEV S A/S stock opened at $2.68 on Friday. The stock has a market cap of $42.15 billion, a price-to-earnings ratio of 19.14, a PEG ratio of 4.24 and a beta of 1.03. The company has a current ratio of 1.23, a quick ratio of 0.93 and a debt-to-equity ratio of 0.04. The company’s 50-day moving average price is $2.71 and its two-hundred day moving average price is $2.89. AMBEV S A/S has a 52 week low of $1.90 and a 52 week high of $5.40.
AMBEV S A/S (NYSE:ABEV) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.02 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.04 by ($0.02). AMBEV S A/S had a net margin of 17.92% and a return on equity of 13.70%. The business had revenue of $2.85 billion for the quarter, compared to the consensus estimate of $3.13 billion. Research analysts expect that AMBEV S A/S will post 0.11 earnings per share for the current fiscal year.
A number of research firms recently weighed in on ABEV. TheStreet raised shares of AMBEV S A/S from a “d+” rating to a “c-” rating in a report on Monday, July 27th. Zacks Investment Research raised shares of AMBEV S A/S from a “sell” rating to a “hold” rating in a research note on Monday, July 13th. Finally, JPMorgan Chase & Co. raised shares of AMBEV S A/S from an “underweight” rating to a “neutral” rating in a research note on Friday. Three investment analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. The company has an average rating of “Hold” and a consensus target price of $3.70.
AMBEV S A/S Profile
Ambev SA, through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks (CSD), other non-alcoholic beverages, malt, and food products in the Americas. It operates through three segments: Latin America North, Latin America South, and Canada. The company offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Brahva Gold, Extra, Budweiser, Bud Light, Stella Artois, Corona, Modelo Especial, Beck, Leffe, Hoegaarden, Presidente, Brahma Light, President Light, Bohemia, The One, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Báltica, Ouro Fino, Pilsen, Patricia, Labatt Blue, Alexander Keith's, Kokanee, Banks, and Deputy brands.
Featured Story: Overbought
Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMBEV S A/S (NYSE:ABEV).
Receive News & Ratings for AMBEV S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMBEV S A/S and related companies with MarketBeat.com's FREE daily email newsletter.